Medidata Solutions (MDSO) - FREE Research Report

De Vries Glen Michael who is President at Medidata Solutions sold 20,000 shares at $59.35 on Jan. 16, 2014. Following this transaction, the President owned 972,666 shares meaning that the stake was reduced by 2.01% with the 20,000-share transaction.

The shares most recently traded at $60.64, up $1.29, or 2.13% since the insider transaction. Historical insider transactions for Medidata Solutions go as follows:

  • 4-Week # shares sold: 20,000
  • 12-Week # shares sold: 200,332
  • 24-Week # shares sold: 200,332

The average volume for Medidata Solutions has been 473,800 shares per day over the past 30 days. Medidata Solutions has a market cap of $3.3 billion and is part of the technology sector and computer software & services industry. Shares are up 1.4% year-to-date as of the close of trading on Thursday.

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally. The company has a P/E ratio of 141.7. Currently there are 5 analysts that rate Medidata Solutions a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDSO - FREE

TheStreet Quant Ratings rates Medidata Solutions as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Medidata Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

What's Doing Best in New Portfolio? Take a Guess

Random Action as Market Prepares for Jackson Hole

We're Seeing the First Signs of Serious Efforts on Tax Reform: Market Recon

Happy Early Returns From This Value-Oriented Dividend Portfolio